UNICA IRIS Institutional Research Information System

FULGHESU, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 89.291
NA - Nord America 7.464
AS - Asia 3.454
SA - Sud America 453
AF - Africa 73
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 7
Totale 100.770
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 87.253
US - Stati Uniti d'America 7.354
SG - Singapore 1.477
CN - Cina 1.104
UA - Ucraina 564
SE - Svezia 469
BR - Brasile 355
VN - Vietnam 261
FI - Finlandia 220
GB - Regno Unito 210
DE - Germania 196
FR - Francia 172
BD - Bangladesh 141
HK - Hong Kong 104
IN - India 83
CA - Canada 59
IE - Irlanda 58
KR - Corea 57
PK - Pakistan 47
RU - Federazione Russa 44
AR - Argentina 38
MX - Messico 28
AU - Australia 25
IQ - Iraq 21
TR - Turchia 21
NL - Olanda 20
ID - Indonesia 19
PH - Filippine 19
PL - Polonia 17
BE - Belgio 16
CO - Colombia 14
EC - Ecuador 12
EG - Egitto 12
KE - Kenya 12
JP - Giappone 11
UZ - Uzbekistan 11
ZA - Sudafrica 11
CL - Cile 10
ES - Italia 10
NG - Nigeria 10
SA - Arabia Saudita 10
JO - Giordania 8
LT - Lituania 8
NP - Nepal 8
PE - Perù 8
EU - Europa 7
IR - Iran 7
MA - Marocco 7
PY - Paraguay 7
RO - Romania 7
TN - Tunisia 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
VE - Venezuela 6
BH - Bahrain 5
DZ - Algeria 4
IL - Israele 4
KZ - Kazakistan 4
MY - Malesia 4
AT - Austria 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
ET - Etiopia 3
GR - Grecia 3
AL - Albania 2
AO - Angola 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
Totale 100.762
Salva come PNG Salva come JPEG
Città #
Cagliari 84.244
Uta 2.537
Singapore 754
Fairfield 672
Ashburn 633
Woodbridge 482
San Jose 466
Chandler 433
Houston 416
Boardman 397
Dallas 339
Wilmington 305
Nyköping 297
Jacksonville 293
Ann Arbor 287
Seattle 280
Cambridge 246
Beijing 177
Helsinki 148
Los Angeles 145
Nanjing 130
Santa Clara 119
Boston 112
Lauterbourg 109
Dearborn 105
Menlo Park 104
Hefei 100
The Dalles 100
Buffalo 96
Hong Kong 91
Ho Chi Minh City 81
Council Bluffs 65
Hanoi 56
Seoul 54
Shanghai 54
New York 45
Milan 44
San Diego 44
Redwood City 36
Shenyang 34
Hebei 33
Frankfurt am Main 32
Changsha 30
Chicago 30
Guangzhou 27
Nanchang 27
Jiaxing 26
São Paulo 26
Tianjin 26
Toronto 26
Orange 24
Da Nang 19
Rome 19
Norwalk 17
Verona 17
Brooklyn 16
Brussels 15
Lahore 15
London 15
Haiphong 14
San Francisco 14
Warsaw 14
Washington 14
Pune 13
Stockholm 13
Munich 12
Orem 12
Zhengzhou 12
Florence 11
Jinan 11
Belo Horizonte 10
Dublin 10
Naples 10
Phoenix 10
Atlanta 9
Johannesburg 9
Manchester 9
Mexico City 9
Saint Petersburg 9
Tashkent 9
Curitiba 8
Kunming 8
Nairobi 8
Quezon City 8
Redondo Beach 8
Sassari 8
Tokyo 8
Düsseldorf 7
Goiânia 7
Thái Nguyên 7
Amman 6
Amsterdam 6
Ankara 6
Biên Hòa 6
Charlotte 6
Fortaleza 6
Genoa 6
Hải Dương 6
Jeddah 6
Karachi 6
Totale 95.941
Salva come PNG Salva come JPEG
Nome #
IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance 2.856
Is there a dose-response relationship of metformin treatment in patients with polycistic ovary syndrome? Results from a multicentric study 2.596
Stained amniotic fluid: what's new? 2.454
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population 2.335
Il-6 serum levels and production in PCOS adolescents is related to insulin resistance 2.334
Very low dose of flutamide in the treatment of hyperandrogenism 2.309
Inflammatory response to lypopolysaccharide in mononuclear cells from polycystic ovary syndrome insulin resistant adolescent 2.304
Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome 2.049
Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome 1.939
Ultrasound diagnosis of polycystic ovarian syndrome: current guidelines, criticism and possible update 1.893
The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome 1.795
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. 1.710
Ovulation induction in young girls with menometrorragia: a safe and effective treatment 1.687
Obesity related lipid profileand altered insulin incretion in adolescent with policystic ovary syndrome 1.685
L'ovaio nella Sindrome dell'ovaio policistico 1.647
Pathogenesis 1.419
INDICAZIONE AL PARTO CESAREO PRESSO LA CLINICA OSTETRICA E GINECOLOGICA DI CAGLIARI: SU QUALI POSSIAMO RIDURRE IL RICORSO AL PARTO CESAREO? 1.368
Dismenorrea: dalle limitazioni alla quotidianità ai dolori pelvici 1.289
ANALGESIA EPIDURALE E INCIDENZA DI TAGLIO CESAREO. 1.284
Criteri diagnostici di PCOS: recenti evoluzioni 1.262
Diagnosis of metabolic disorders in women with polycystic ovary syndrome 1.261
Ecografia in ginecologia dell'infanzia e dell'adolescenza. Testo atlante 1.250
Obesity realated lipid profile and altered insulin incretion in adolescent with PCOS 1.221
Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome 1.188
Metformin effect on ovarian ultrasoundappearance and steroidogenetic functionin normal weightnormoinsulinemic women with polycystic ovary sindrome:a randomized double blind placebo-controlledclinical trial 1.182
Influenza dei parametri antropometrici sulla risposta alla Metformina in pazienti con PCOS. 1.112
78) PITUITARY – OVARIAN RESPONSE TO GONADOTROPIN- RELESING HORMONE AGONIST TEST IN ANOVULATORY PATIENTS WITH POLYCYSTIC OVARY STROMA. PREDICTIVE ROLE OF OVARIAN STROMA 1.087
null 1.083
Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS) 1.064
Differenze regionali nella risposta alla Metformina in pazienti con PCOS 1.017
133. Metformin effect in PCOS patients is not dose dependent 991
Diagnosi dei problemi metabolici nelle donne con PCOS 985
Ultrasound in PCOS: revisiting Rotterdam criteria 973
Endocrine and metabolic aspects in obese and lean young PCOS 962
The quantitative insulin sensitivity check index (QUICKY) is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome 918
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 884
LA DIAGNOSI ECOGRAFICA DELLA PCOS 863
Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. 856
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study. 854
Ovarian stromal hypertropy and insulin abnormalities in PCOS 825
82. Pituitary-ovarian response to gonadotrpin-releasing hormone-agonist test in anovulatory patients with polycystic ovary sindrome. Predictive role of ovarian stroma 823
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease. 791
Ovarian stroma in PCOS: relationship with circulating androgens 784
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome. 784
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration. 783
Iperinsulinemia in adolescenti affette da PCOS 767
Confronto tra autovalutazione e valutazione clinica dell’irsutismo e dell’immagine corporea in adolescenza 757
Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus 751
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion. 746
Espressione genica e livelli circolanti di resistita in giovani pazienti affette da PCOS 741
null 740
null 735
Good practice in pediatric and adolescent gynecology 727
Assetto lipidico in adolescenti affette da PCOS 725
CHANGES IN LUTEINIZING HORMONE AND INSULIN SECRETION IN POLYCYSTIC OVARIAN SYNDROME 725
Ovarian stromal hypertrophy and insulin abnormalities in young PCOS 700
EFFECT OF OPIOID BLOCKADE ON INSULIN AD GROWTH HORMONE (GH) SECRETION IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME: THE HETEROGENEITY OF IMPAIRED GH SECRETION IS RELATED TO BOTH OBESITY AND HYPERINSULINISM 680
N-ACETYL-CYSTEINE TREATMENT IMPROVES THE INSULIN SENSITIVITY IN PCOS 680
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL-AXIS RESPONSE TO NALOXONE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME 675
Relationship between genetic and metabolic abnormalities in PCOS 662
PRECONCEPTIONAL AND GESTATIONAL EVALUATION OF INSULIN SECRETION IN PATIENTS WITH COLYCYSTIC OVARY SYNDROME 649
Knowledge of the microbiota: personal experience from 324 questionnaires administered to mother and mothers-to-be. 610
THE IMPACT OF INSULIN SECRETION ON THE OVARIAN RESPONSE TO EXOGENOUS GONADOTROPINS IN POLYCYSTIC OVARY SYNDROME 605
The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside. A Systematic Literature Review 585
ACUTE INSULIN RESPONSE TO INTRAVENOUS GLUCAGONE IN POLYCYSTIC OVARY SYNDROME 579
EVIDENCE OF A DISTINCT DERANGEMENT OF OPIOID TONE IN HYPERINSULINEMIC PATIENTS WITH POLYCYSTIC OVARY SYNDROME: RELATIONSHIP WITH INSULIN AND LUTEINIZING HORMONE 578
CORTICOTROPIN RELEASING HORMONE INDUCES AN EXAGGERATED RESPONSE OF ADRENOCORTICOTROPIC HORMONE AND CORTISOL IN POLYCYSTIC OVARY SYNDROME 568
null 565
Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome 549
An open multicenter study to compare the efficacy of intraperitoneal insemination and intrauterine insemination following multiple follicular development as treatment for unexplained infertility 529
Ultrasound in polycystic ovary syndrome--the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study 527
SOMATOSTATIN TREATMENT REDUCES THE EXAGGERATED RESPONSE OF ADRENOCORTICOTROPIN HORMONE AND CORTISOL TO CORTICOTROPIN -RELEASING HORMONE IN POLYCYSTIC OVARY SYNDROME 524
EFFECT OF OPIOID BLOCKADE ON INSULIN METABOLISM IN POLYCYSYIC OVARIAN DISEASE 521
ENDOCRINO-METABOLIC FEATURES IN WOMEN WITH POLYCYSTIC OVARY SYNDROME DURING PREGNANCY 515
Hirsutism and hyperandrogenism associated with hyperreactio luteinalis in a singleton pregnancy: a case report. 502
La clinica dei disturbi mestruali in adolescenza: risultati di un’analisi sul territorio 497
EVIDENCE OF A DISTURBANCE OF THE HYPOTALAMIC PITUITARY ADRENAL AXIS IN POLYCYSTIC OVARY SYNDROME EFFECT OF NALOXONE 486
GROWTH HORMONE ENHANCES ESTRADIOL PRODUCTION FSH INDUCED IN THE EARLY STAGE OF THE FOLLICULAR MATURATION 470
TEMPOROLIMBIC EPILEPSY AND POLYCYSTIC OVARY SYNDROME 465
EFFECTIVENESS OF A SOMATOSTATIN ANALOGUE IN LOWERING LH AND INSULIN SECRETION IN HYPERINSULINEMIC WOMEN WITH POLYCYSTIC OVARIAN DISEASE 462
Get a clear view before starting: Endometrial preparation with hormones 453
Which treatment options should be used in adolescents with polycystic ovary syndrome? 443
La clinica dei disturbi mestruali in adolescenza: risultati di un’analisi sul territorio 441
Polycystic Ovarian Morphology in Normocyclic Non-hyperandrogenic Adolescents 441
Prevalenza dei markers di autoimmunità nelle pazienti affette da preeclampsia 430
Influenza del peso sulla risposta al test all’analogo del GnRH (GnRHa) in PCOS 429
HETEROGENEITY IN ß- CELL ACTIVITY, HEPATIC INSULIN CLEARANCE AND PERIPHERAL INSULIN SENSITIVITY IN WOMEN WITH POLYCYCSTIC OVARY SYNDROME 422
Correlation of ovarian stromal hypertrophy to hyperandrogenism and insulin resistance in young women with PCOS 420
Adolescence and hyperinsulinemia: it is always the first step towards PCOS? 414
Studio osservazionale sulle irregolarità mestruali in adolescenza 411
Insulin and GH secretion in adolescent girls with irregular cycles: polycystic vs multifollicular ovaries 398
null 395
Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. 348
A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. 346
Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist. 333
Importance of echographic and endocrine monitoring for the assessment of ovulation by follicle stimulating hormone in polycystic ovarian disease. 333
Comment on "Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome". 331
Effect of maternal carbohydrate metabolism on fetal growth. 328
Luteal responses to gonadotropin-releasing hormone during the luteal phase: relation to the age of corpus luteum. 325
Progesterone and LH variations after LH-RH administration in the luteal phase of the menstrual cycle. 318
Totale 92.112
Salva come PNG Salva come JPEG
Categoria #
all - tutte 144.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.281
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.423 614 410 311 304 515 287 509 400 308 505 610 650
2022/20239.880 708 1.033 1.217 923 568 769 462 914 817 819 1.217 433
2023/202412.200 404 338 372 574 1.147 2.068 2.134 633 1.185 884 1.364 1.097
2024/202514.395 1.871 3.195 2.302 2.372 1.262 1.169 1.063 94 252 269 239 307
2025/20265.997 344 405 772 365 418 541 887 485 473 568 527 212
2026/202778 78 0 0 0 0 0 0 0 0 0 0 0
Totale 101.104